153 related articles for article (PubMed ID: 20610384)
1. CCCTC-binding factor acts upstream of FOXA1 and demarcates the genomic response to estrogen.
Zhang Y; Liang J; Li Y; Xuan C; Wang F; Wang D; Shi L; Zhang D; Shang Y
J Biol Chem; 2010 Sep; 285(37):28604-13. PubMed ID: 20610384
[TBL] [Abstract][Full Text] [Related]
2. A co-ordinated interaction between CTCF and ER in breast cancer cells.
Ross-Innes CS; Brown GD; Carroll JS
BMC Genomics; 2011 Dec; 12():593. PubMed ID: 22142239
[TBL] [Abstract][Full Text] [Related]
3. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function.
Jiang G; Wang X; Sheng D; Zhou L; Liu Y; Xu C; Liu S; Zhang J
Theranostics; 2019; 9(22):6501-6516. PubMed ID: 31588232
[TBL] [Abstract][Full Text] [Related]
4. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.
Laganière J; Deblois G; Lefebvre C; Bataille AR; Robert F; Giguère V
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11651-6. PubMed ID: 16087863
[TBL] [Abstract][Full Text] [Related]
5. FOXA1 is a key determinant of estrogen receptor function and endocrine response.
Hurtado A; Holmes KA; Ross-Innes CS; Schmidt D; Carroll JS
Nat Genet; 2011 Jan; 43(1):27-33. PubMed ID: 21151129
[TBL] [Abstract][Full Text] [Related]
6. FOXP1 and estrogen signaling in breast cancer.
Ijichi N; Ikeda K; Horie-Inoue K; Inoue S
Vitam Horm; 2013; 93():203-12. PubMed ID: 23810008
[TBL] [Abstract][Full Text] [Related]
7. GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility.
Theodorou V; Stark R; Menon S; Carroll JS
Genome Res; 2013 Jan; 23(1):12-22. PubMed ID: 23172872
[TBL] [Abstract][Full Text] [Related]
8. CTCF modulates Estrogen Receptor function through specific chromatin and nuclear matrix interactions.
Fiorito E; Sharma Y; Gilfillan S; Wang S; Singh SK; Satheesh SV; Katika MR; Urbanucci A; Thiede B; Mills IG; Hurtado A
Nucleic Acids Res; 2016 Dec; 44(22):10588-10602. PubMed ID: 27638884
[TBL] [Abstract][Full Text] [Related]
9. Genomic responses from the estrogen-responsive element-dependent signaling pathway mediated by estrogen receptor alpha are required to elicit cellular alterations.
Nott SL; Huang Y; Li X; Fluharty BR; Qiu X; Welshons WV; Yeh S; Muyan M
J Biol Chem; 2009 May; 284(22):15277-88. PubMed ID: 19321454
[TBL] [Abstract][Full Text] [Related]
10. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
Klinge CM
J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
[TBL] [Abstract][Full Text] [Related]
11. Estrogen induces repression of the breast cancer and salivary gland expression gene in an estrogen receptor alpha-dependent manner.
Bretschneider N; Brand H; Miller N; Lowery AJ; Kerin MJ; Gannon F; Denger S
Cancer Res; 2008 Jan; 68(1):106-14. PubMed ID: 18172302
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6.
Yamaguchi N; Nakayama Y; Yamaguchi N
J Biol Chem; 2017 May; 292(20):8136-8148. PubMed ID: 28270510
[TBL] [Abstract][Full Text] [Related]
13. KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function.
Gala K; Li Q; Sinha A; Razavi P; Dorso M; Sanchez-Vega F; Chung YR; Hendrickson R; Hsieh JJ; Berger M; Schultz N; Pastore A; Abdel-Wahab O; Chandarlapaty S
Oncogene; 2018 Aug; 37(34):4692-4710. PubMed ID: 29755131
[TBL] [Abstract][Full Text] [Related]
14. Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ERα in Tamoxifen-Associated Endometrial Carcinomas.
Droog M; Nevedomskaya E; Kim Y; Severson T; Flach KD; Opdam M; Schuurman K; Gradowska P; Hauptmann M; Dackus G; Hollema H; Mourits M; Nederlof P; van Boven H; Linn SC; Wessels L; van Leeuwen FE; Zwart W
Cancer Res; 2016 Jul; 76(13):3773-84. PubMed ID: 27197147
[TBL] [Abstract][Full Text] [Related]
15. GalNAc-T4 putatively modulates the estrogen regulatory network through FOXA1 glycosylation in human breast cancer cells.
Niang B; Jin L; Chen X; Guo X; Zhang H; Wu Q; Padhiar AA; Xiao M; Fang D; Zhang J
Mol Cell Biochem; 2016 Jan; 411(1-2):393-402. PubMed ID: 26541755
[TBL] [Abstract][Full Text] [Related]
16. Regulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancer.
Johnsen SA; Güngör C; Prenzel T; Riethdorf S; Riethdorf L; Taniguchi-Ishigaki N; Rau T; Tursun B; Furlow JD; Sauter G; Scheffner M; Pantel K; Gannon F; Bach I
Cancer Res; 2009 Jan; 69(1):128-36. PubMed ID: 19117995
[TBL] [Abstract][Full Text] [Related]
17. Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cells.
Holmes KA; Hurtado A; Brown GD; Launchbury R; Ross-Innes CS; Hadfield J; Odom DT; Carroll JS
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2748-53. PubMed ID: 21536917
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase 7 and FoxA1 in estrogen-mediated repression of RPRM.
Malik S; Jiang S; Garee JP; Verdin E; Lee AV; O'Malley BW; Zhang M; Belaguli NS; Oesterreich S
Mol Cell Biol; 2010 Jan; 30(2):399-412. PubMed ID: 19917725
[TBL] [Abstract][Full Text] [Related]
19. DNA binding by estrogen receptor-alpha is essential for the transcriptional response to estrogen in the liver and the uterus.
Ahlbory-Dieker DL; Stride BD; Leder G; Schkoldow J; Trölenberg S; Seidel H; Otto C; Sommer A; Parker MG; Schütz G; Wintermantel TM
Mol Endocrinol; 2009 Oct; 23(10):1544-55. PubMed ID: 19574448
[TBL] [Abstract][Full Text] [Related]
20. CCCTC-binding factor confines the distal action of estrogen receptor.
Chan CS; Song JS
Cancer Res; 2008 Nov; 68(21):9041-9. PubMed ID: 18974150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
